Satiety develops minimally invasive medical devices for the treatment of moderate & morbid obesity. The TOGa Procedure is a completely transoral procedure designed to achieve similar weight loss to restrictive surgeries. The procedure is designed to be less invasive, require significantly less recovery time and have dramatically reduced complications, compared to existing surgical options. In the TOGa Procedure, the physician introduces a stapling device transorally and creates a restrictive pouch at the entry of the stomach. The effect is anatomically similar to other restrictive procedures, which physically restrict the amount of food a patient can eat. The procedure is non-surgical, endoscopic, and may be performed by properly trained bariatric surgeons, general endoscopic surgeons, and gastroenterologists. The TOGa System is an investigational device, and is not approved by the FDA or any other regulatory agency.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 07/17/07 | Series D | 30M | Unknown |